Michael Chambers
Fortune : 11 M $ au 31/08/2026
Fortune : 11 M $ au 31/08/2026
Mr. Michael Chambers is an Independent Director at Sarepta Therapeutics, Inc. He is on the Board of Directors at Whitehead Institute for Biomedical Research, Sarepta Therapeutics, Inc., Calviri, Inc., Agathos Biologics LLC and Lykan Biosciences LLC.
Mr. Chambers was previously employed as a Chief Executive Officer & Director by Altravax, Inc. and a Chairman by Aldevron LLC.
He also served on the board at NDSU Research Technology Park, Inc. He received his undergraduate degree from North Dakota State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 504 027 ( 0,48 % ) | 11 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/06/2022 |
Calviri, Inc.
Calviri, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines to eliminate cancer | Directeur/Membre du Conseil | 18/08/2020 |
Lykan Biosciences LLC | Directeur/Membre du Conseil | - |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Directeur/Membre du Conseil | 08/12/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Directeur Général | 13/07/2020 |
NDSU Research Technology Park, Inc.
NDSU Research Technology Park, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a research and technology park where university researchers and private industry develops new technologies | Directeur/Membre du Conseil | - |
Altravax, Inc.
Altravax, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new vaccines to fight infectious diseases | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Altravax, Inc.
Altravax, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops new vaccines to fight infectious diseases | Health Technology |
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Health Technology |
North Dakota State University
North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
NDSU Research Technology Park, Inc.
NDSU Research Technology Park, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a research and technology park where university researchers and private industry develops new technologies | Commercial Services |
Calviri, Inc.
Calviri, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops vaccines to eliminate cancer | Health Technology |
Lykan Biosciences LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national